 |
市場調查報告書
商品編碼
1550566
Leuprolide Acetate的全球市場：按應用、按產品形式、途徑、按分銷管道、按地區Leuprolide Acetate Market, By Application, By Product Form, By Route of Administration, By Distribution Channel, By Geography |
||||||
預計2024年全球Leuprolide Acetate市場規模將達38.2億美元，2024年至2031年複合年成長率為6.2%，2031年將達58.1億美元。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年 | 2023年 | 2024年市場規模 | 38.2億美元 |
| 實際資料 | 2019-2023 | 預測期 | 2024-2031 |
| 預測 2024-2031 年複合年成長率： | 6.20% | 2031 年金額預測 | 58.1億美元 |
Leuprolide Acetate的全球市場是指Leuprolide Acetate藥物的醫藥市場，醋酸亮丙瑞林是天然存在的促性腺激素分泌釋放激素（GnRH）的合成非勝胜肽類似物。Leuprolide Acetate用於治療攝護腺癌、乳癌、子宮內膜異位症和子宮肌瘤。作為促性腺激素分泌釋放激素（GnRH）受體的促效劑，Leuprolide Acetate透過減少腦下垂體中FSH和LH的分泌來發揮作用，有助於治療上述疾病。在預測期內，使用Leuprolide Acetate作為治療劑的癌症和其他疾病的發生率不斷增加，可能會推動全球Leuprolide Acetate市場的成長。
市場動態：
全球攝護腺癌、乳癌、子宮內膜異位症和子宮肌瘤盛行率的上升可能會推動全球Leuprolide Acetate市場的成長。根據世界癌症研究基金會的數據，攝護腺癌是全世界男性第二常見的癌症。新興市場有利的藥物核准情況和不斷增加的醫療保健支出將推動市場成長。然而，與Leuprolide Acetate製劑相關的高成本以及一些國家對替代治療方法的偏好可能會阻礙市場成長。Leuprolide Acetate創新藥物輸送系統的持續研發活動可以在不久的將來為市場參與者提供潛在的機會。
本研究的主要特點
本報告對全球Leuprolide Acetate市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模（十億美元）和年複合成長率（CAGR%） 。
它還說明了各個細分市場的潛在商機，並為該市場提供了一系列有吸引力的投資提案。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
根據公司亮點、產品系列、主要亮點、績效和策略等參數，介紹了全球Leuprolide Acetate市場的主要企業概況。
本研究涵蓋的主要企業包括武田製藥、麗珠製藥、北京博奧特、賽諾菲、太陽製藥、艾伯維、輝瑞等。
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
Leuprolide Acetate全球市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過在分析全球Leuprolide Acetate市場時所使用的各種策略矩陣來促進他們的決策。
目錄
第1章 研究目的與前提
- 研究目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
第3章市場動態、法規及趨勢分析
- 市場動態
- 影響分析
- 主要亮點
- 監管場景
- 產品發布/核准
- PEST分析
- 波特的分析
- 併購場景
第4章全球Leuprolide Acetate市場，依應用分類，2019-2031（十億美元）
- 攝護腺癌
- 子宮內膜異位症
- 子宮肌瘤
- 中樞性早熟症
- 不孕症
- 荷爾蒙療法
- 其他
第5章全球Leuprolide Acetate市場，依產品形式，2019-2031（十億美元）
- 預填充式注射器
- 管瓶
- 凍乾粉
第6章 全球Leuprolide Acetate市場，依給藥途徑，2019-2031 年（十億美元）
- 肌肉注射
- 皮下的
- 經皮的
- 移植
第 7 章 全球Leuprolide Acetate市場，依通路分類，2019-2031 年（十億美元）
- 醫院藥房
- 零售藥房
- 網路藥房
第8章全球Leuprolide Acetate市場，按地區，2019-2031（十億美元）
- 拉丁美洲
- 歐洲
- 亞太地區
第9章 中東
- 按應用分類的市場規模和預測（十億美元）
- 按產品類型分類的市場規模和預測（十億美元）
- 按管理途徑分類的市場規模和預測（十億美元）
- 按分銷管道分類的市場規模和預測（十億美元）
- 按國家/地區分類的市場規模和預測（十億美元）
- 海灣合作理事會國家
- 以色列
- 其他中東地區
- 非洲
- 按應用分類的市場規模和預測（十億美元）
- 按產品類型分類的市場規模和預測（十億美元）
- 按管理途徑分類的市場規模和預測（十億美元）
- 按分銷管道分類的市場規模和預測（十億美元）
- 按國家/地區分類的市場規模和預測（十億美元）
- 南非
- 北非
- 中部非洲
第10章競爭格局
- Sun Pharmaceutical Industries Ltd.
- AbbVie Inc.
- Teva Pharmaceutical Industries Ltd.
- Mylan NV
- Ferring Pharmaceuticals
- GSK（GlaxoSmithKline）
- Bayer AG
- Pfizer Inc.
- Hikma Pharmaceuticals PLC
- Aurobindo Pharma
- Amgen Inc.
- EMD Serono, Inc.
- Novartis AG
- Sandoz International GmbH
- Apotex Inc.
- Fresenius Kabi AG
- Bausch Health Companies Inc.
- Hetero Labs Limited
- ZydusCadila
- Cipla Limited
第11章分析師建議
- 命運之輪
- 分析師觀點
- 一致的機會圖
第12章參考文獻與調查方法
- 參考
- 調查方法
- 出版商
Global leuprolide acetate market is estimated to be valued at USD 3.82 Billion in 2024 and is expected to reach USD 5.81 Billion by 2031, exhibiting a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 3.82 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 6.20% | 2031 Value Projection: | US$ 5.81 Bn |
Global leuprolide acetate market refers to the pharmaceutical market for leuprolide acetate drugs, which is a synthetic nonapeptide analog of naturally occurring gonadotropin-releasing hormone (GnRH). Leuprolide acetate is used as a medication to treat prostate cancer, breast cancer, endometriosis and uterine fibroids. As an agonist of gonadotropin-releasing hormone (GnRH) receptor, leuprolide acetate works by reducing the secretion of FSH and LH from the pituitary gland which helps in treatment of above-mentioned conditions. Increasing incidence of cancers and other disorders for which leuprolide acetate is used as a therapeutic drug can drive the global leuprolide acetate market growth during the forecast period.
Market Dynamics:
Rising prevalence of prostate cancer, breast cancer, endometriosis and uterine fibroids across the globe can drive the global leuprolide acetate market growth. According to World Cancer Research Fund, prostate cancer is the second most commonly diagnosed cancer in men globally. Favorable drug approval scenario and increasing healthcare expenditure in developing nations can drive the market growth. However, high costs associated with leuprolide acetate drugs and preference of alternative treatment options in some countries can hamper the market growth. Ongoing research & development activities for development of innovative drug delivery systems of leuprolide acetate can provide potential opportunities for market players in the near future.
Key features of the study:
This report provides in-depth analysis of the global leuprolide acetate market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global leuprolide acetate market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Takeda Pharmaceuticals, Livzon Pharmaceutical, Beijing Biote, Sanofi, Sun Pharmaceutical, AbbVie, and Pfizer.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global leuprolide acetate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global leuprolide acetate market
Detailed Segmentation-
- By Application
- Prostate Cancer
- Endometriosis
- Uterine Fibroids
- Central Precocious Puberty
- Infertility
- Hormone Therapy
- Others
- By Product Form
- Pre-filled Syringes
- Vials
- Lyophilized Powder
- By Route of Administration
- Intramuscular
- Subcutaneous
- Intranasal
- Implantation
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Key Players Insights
- Sun Pharmaceutical Industries Ltd.
- AbbVie Inc.
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Ferring Pharmaceuticals
- GSK (GlaxoSmithKline)
- Bayer AG
- Pfizer Inc.
- Hikma Pharmaceuticals PLC
- Aurobindo Pharma
- Amgen Inc.
- EMD Serono, Inc.
- Novartis AG
- Sandoz International GmbH
- Apotex Inc.
- Fresenius Kabi AG
- Bausch Health Companies Inc.
- Hetero Labs Limited
- Zydus Cadila
- Cipla Limited
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Leuprolide Acetate Market, By Application
- Global Leuprolide Acetate Market, By Product Form
- Global Leuprolide Acetate Market, By Route of Administration
- Global Leuprolide Acetate Market, By Distribution Channel
- Global Leuprolide Acetate Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Leuprolide Acetate Market, By Application, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Prostate Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Endometriosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Uterine Fibroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Central Precocious Puberty
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Infertility
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Hormone Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
5. Global Leuprolide Acetate Market, By Product Form, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Pre-filled Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Vials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Lyophilized Powder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Leuprolide Acetate Market, By Route of Administration, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Subcutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Intranasal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Implantation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Leuprolide Acetate Market, By Distribution Channel, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Leuprolide Acetate Market, By Region, 2019 - 2031, USD Bn)
- Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Product Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Product Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Product Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Product Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
9. Middle East
- Introduction
- Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Product Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Product Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country/Sub-region, 2019 - 2031, (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Sun Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mylan N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ferring Pharmaceuticals
- GSK (GlaxoSmithKline)
- Bayer AG
- Pfizer Inc.
- Hikma Pharmaceuticals PLC
- Aurobindo Pharma
- Amgen Inc.
- EMD Serono, Inc.
- Novartis AG
- Sandoz International GmbH
- Apotex Inc.
- Fresenius Kabi AG
- Bausch Health Companies Inc.
- Hetero Labs Limited
- ZydusCadila
- Cipla Limited
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
